Skip to main content

Corporate insider profile

Suma Krishnan Insider Trades

Suma Krishnan has reported no open-market purchases on SEC Form 4 and is a net seller of $16,685,810 across 1 company. The most recent open-market transaction was reported on Sep 4, 2026. Source: SEC Form 4 filings.

Latest reported as President, R&D of Krystal Biotech, Inc. (KRYS).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$16,685,810.00
Latest transaction
Sep 4, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 4, 2026Krystal Biotech, Inc. (KRYS)President, R&DSale25,000$359.32$8,982,985
Jun 4, 2026Krystal Biotech, Inc. (KRYS)President, R&DSale25,000$308.11$7,702,825

Common questions

Suma Krishnan insider trading FAQ

Is Suma Krishnan buying or selling stock?
Across all SEC Form 4 open-market filings on record, Suma Krishnan is a net seller of $16,685,810, with no open-market purchases reported. The latest transaction was reported on Sep 4, 2026.
Which companies does Suma Krishnan report insider trades for?
Suma Krishnan has reported open-market trades in Krystal Biotech, Inc. (KRYS). The latest SEC-reported relationship is President, R&D of Krystal Biotech, Inc. (KRYS).
Where does Suma Krishnan's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1298711, and refreshes this page daily.